» Articles » PMID: 31835701

Influence of Selected Carbon Nanostructures on the CYP2C9 Enzyme of the P450 Cytochrome

Overview
Publisher MDPI
Date 2019 Dec 15
PMID 31835701
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Carbon nanostructures have recently gained significant interest from scientists due to their unique physicochemical properties and low toxicity. They can accumulate in the liver, which is the main expression site of cytochrome P450 (CYP450) enzymes. These enzymes play an important role in the metabolism of exogenous compounds, such as drugs and xenobiotics. Altered activity or expression of CYP450 enzymes may lead to adverse drug effects and toxicity. The objective of this study was to evaluate the influence of three carbon nanostructures on the activity and expression at the mRNA and protein levels of CYP2C9 isoenzyme from the CYP2C subfamily: Diamond nanoparticles, graphite nanoparticles, and graphene oxide platelets. The experiments were conducted using two in vitro models. A microsome model was used to assess the influence of the three-carbon nanostructures on the activity of the CYP2C9 isoenzyme. The CYP2C9 gene expression at the mRNA and protein levels was determined using a hepatoma-derived cell line HepG2. The experiments have shown that all examined nanostructures inhibit the enzymatic activity of the studied isoenzymes. Moreover, a decrease in the expression at the mRNA and protein levels was also observed. This indicates that despite low toxicity, the nanostructures can alter the enzymatic function of CYP450 enzymes, and the molecular pathways involved in their expression.

Citing Articles

Sub-Lethal Concentrations of Graphene Oxide Trigger Acute-Phase Response and Impairment of Phase-I Xenobiotic Metabolism in Upcyte Hepatocytes.

Romaldini A, Spano R, Catalano F, Villa F, Poggi A, Sabella S Front Bioeng Biotechnol. 2022; 10:867728.

PMID: 35662849 PMC: 9161028. DOI: 10.3389/fbioe.2022.867728.


Effect of Graphene Family Materials on Multiple Myeloma and Non-Hodgkin's Lymphoma Cell Lines.

Strojny B, Jaworski S, Misiewicz-Krzeminska I, Isidro I, Rojas E, Gutierrez N Materials (Basel). 2020; 13(15).

PMID: 32756412 PMC: 7436021. DOI: 10.3390/ma13153420.

References
1.
Niwa T, Yamazaki H . Comparison of cytochrome P450 2C subfamily members in terms of drug oxidation rates and substrate inhibition. Curr Drug Metab. 2012; 13(8):1145-59. DOI: 10.2174/138920012802850092. View

2.
Zakrzewska K, Samluk A, Wierzbicki M, Jaworski S, Kutwin M, Sawosz E . Analysis of the cytotoxicity of carbon-based nanoparticles, diamond and graphite, in human glioblastoma and hepatoma cell lines. PLoS One. 2015; 10(3):e0122579. PMC: 4376528. DOI: 10.1371/journal.pone.0122579. View

3.
Pan Y, Ong C, Pung Y, Chieng J . The current understanding of the interactions between nanoparticles and cytochrome P450 enzymes - a literature-based review. Xenobiotica. 2018; 49(7):863-876. DOI: 10.1080/00498254.2018.1503360. View

4.
Rahmati M, Mozafari M . Biological Response to Carbon-Family Nanomaterials: Interactions at the Nano-Bio Interface. Front Bioeng Biotechnol. 2019; 7:4. PMC: 6351449. DOI: 10.3389/fbioe.2019.00004. View

5.
Jonas D, McLeod H . Genetic and clinical factors relating to warfarin dosing. Trends Pharmacol Sci. 2009; 30(7):375-86. DOI: 10.1016/j.tips.2009.05.001. View